SCHEMBL4124390

SCHEMBL4124390

CCN(CC)CCN(CCNC(=O)OC(C)(C)C)C(=O)Nc1ccc(C(F)(F)F)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCHR1 Q99705 5/20 0.54
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ POLB P06746 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ NFKB1 P19838 1/20 0.41
▸ KCNH2 Q12809 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ MTOR P42345 1/20 0.40
▸ MAPT P10636 1/20 0.39
▸ LMNA P02545 2/20 0.39
▸ HTT P42858 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CKS1B P61024 1/20 0.38
▸ SKP1 P63208 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4120374 0.94 MCHR1 (0.53) MCHR1MEN1KMT2APOLBALDH1A1
SCHEMBL4119233 0.89 UTS2R (0.46) MCHR1MEN1KMT2AMTORMAPT
SCHEMBL4115223 0.87 FPR3 (0.46) MCHR1MEN1KMT2APOLBALDH1A1
SCHEMBL4125813 0.87 GHSR (0.46) MCHR1MEN1KMT2ACYP3A4MTOR
SCHEMBL4118376 0.86 MCHR1 (0.66) MCHR1MEN1KMT2APOLBALDH1A1
SCHEMBL4119975 0.85 UTS2R (0.42) MCHR1MEN1KMT2ASMN1; SMN2MTOR
SCHEMBL4115328 0.82 MCHR1 (0.61) MCHR1MEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL4114315 0.82 EPHX2 (0.50) ALDH1A1KCNH2MAPT
SCHEMBL4107568 0.82 MCHR1 (0.58) MCHR1MEN1KMT2ACYP3A4
SCHEMBL4107405 0.81 MCHR1 (0.60) MCHR1MEN1KMT2APOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118330-A1 Diurea derivatives ACTIVE BIOTECH AB (SE) 2009-05-07 — — US disclosed
EP-1711175-A1 DIUREA DERIVATIVES Active Biotech AB (SE) 2006-10-18 — — EP disclosed
WO-2005074919-A1 DIUREA DERIVATIVES ACTIVE BIOTECH AB (SE) 2005-08-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118330-A1 Diurea derivatives IL2, CASP2, MAVS MCHR1 4128/4885MEN1 4167/4885KMT2A 2720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback